What is Colorectal cancer?

Reading time: 3 min

Colorectal cancer is a type of tumour that develops in the intestine. It is the third most common type of cancer in men, after prostate and lung cancers, and the second most in women, after breast cancer. Colorectal cancer is a preventable and curable disease because the tumour is initially a polyp for several years; if the polyp is detected in time, then it is removed immediately before it can progress to cancer.

The term cancer encompasses a very large group of illnesses that are all characterised by abnormal cell growth; cancer cells divide and grow in an uncontrolled manner and in any part of the body. Most colorectal cancers (called adenocarcinomas) derive from disorderly growth of cells covering the large intestine.

Types of colorectal cancer

Most of the points addressed in this pathology monograph are common to both cancers of the colon and rectum, which is why they are typically called colorectal cancers. However, the progression pattern, and consequently the treatment guidelines and prognosis, can vary according to whether the cancer is located in the colon or the rectum due to their anatomical differences.

Colon cancer primarily spreads over a distance, giving rise to metastasis (propagation from the cancer focus to an organ other than where it initially developed), particularly to the liver. That is why treatment usually involves surgical removal and the administration of complementary chemotherapy.

Rectal cancer, on the other hand, presents a greater likelihood of locoregional progression due to the proximity of other structures found in the pelvic cavity and consequently treatment generally includes radiotherapy and chemotherapy, before or after surgical removal. If distant metastases develop, then they tend to occur in the liver (tumours located in the upper third of the rectum) or the lungs (tumours originally situated in the middle or lower thirds of the rectum).

Overall, the prognosis for colon cancer is more favourable than for rectal cancer, but it essentially depends on the tumour stage at the time of diagnosis.

How many people are affected by colon and rectal cancer?

Considering both sexes together, colorectal cancer is the most frequently diagnosed of all tumours. Taking each sex separately, colorectal cancer is the third most common type of cancer in men, after prostate and lung cancers, and the second most in women, after breast cancer. Over 28,000 new cases are diagnosed in Spain every year.

Despite significant advances in its treatment, colorectal cancer is still the second highest cause of all cancer deaths. In fact, each year more than 15,000 people in Spain die due to this disease.

Colorectal cancer is generally first diagnosed in people aged between 60 and 70 years. By contrast, if there is a family history of this type of neoplasm, and especially when the tumour develops in the context of a hereditary disease, then the onset is earlier, usually before the age of 50. It is a disease that affects both men and women, although the prevalence is slightly higher in men.

Colorectal cancer explained in first person

Appointment of Estela Pineda, Oncologist
Colorectal cancer can be cured. Fortunately, most patients are diagnosed at an early stage of the illness, which means that surgery, or surgery followed by chemotherapy, is enough to cure most patients.
Appointment of José, Patient
I would tell anyone who has just been diagnosed with colon cancer that they should remain optimistic. Based on my experience, a very high percentage of patients with an early diagnosis overcome the disease.

Related content

What is Cancer?

General information about Cancer

Read more

Substantiated information by:

Antonio Maria Lacy Fortuny
Estela Pineda Losada
Francesc Balaguer Prunes
Mª Rosa Costa Quintàs

Published: 20 February 2018
Updated: 20 February 2018

The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.


Receive the latest updates related to this content.

Thank you for subscribing!

If this is the first time you subscribe you will receive a confirmation email, check your inbox

An error occurred and we were unable to send your data, please try again later.